News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
813,075 Results
Type
Article (74243)
Company Profile (643)
Press Release (738189)
Multimedia
Podcasts (119)
Webinars (13)
Section
Business (226476)
Career Advice (3714)
Deals (39133)
Drug Delivery (129)
Drug Development (88902)
Employer Resources (198)
FDA (17769)
Job Trends (17075)
News (385900)
Policy (38584)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (55819)
ALS (97)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (144)
Approvals (17733)
Artificial intelligence (285)
Autoimmune disease (27)
Automation (15)
Bankruptcy (402)
Best Places to Work (12632)
BIOSECURE Act (21)
Biosimilars (118)
Biotechnology (439)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (284)
Cancer (2247)
Cardiovascular disease (195)
Career advice (3161)
Career pathing (33)
CAR-T (164)
Cell therapy (456)
Cervical cancer (21)
Clinical research (71685)
Collaboration (869)
Compensation (526)
Complete response letters (30)
COVID-19 (2859)
CRISPR (45)
C-suite (245)
Cystic fibrosis (107)
Data (2107)
Decentralized trials (2)
Denatured (39)
Depression (51)
Diabetes (283)
Diagnostics (6896)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (129)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (93049)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (128156)
Executive appointments (738)
FDA (19019)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (115)
Generative AI (28)
Gene therapy (335)
GLP-1 (838)
Government (5097)
Grass and pollen (5)
Guidances (51)
Healthcare (20866)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (139)
Indications (27)
Infectious disease (3017)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (95)
Interviews (726)
IPO (17703)
IRA (51)
Job creations (4936)
Job search strategy (2589)
Kidney cancer (10)
Labor market (40)
Layoffs (545)
Leadership (21)
Legal (9871)
Liver cancer (78)
Lung cancer (326)
Lymphoma (144)
Machine learning (5)
Management (65)
Manufacturing (319)
MASH (70)
Medical device (14583)
Medtech (14588)
Mergers & acquisitions (21943)
Metabolic disorders (757)
Multiple sclerosis (82)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (31)
Neuroscience (2060)
NextGen: Class of 2025 (7633)
Non-profit (5075)
Northern California (2600)
Now hiring (39)
Obesity (413)
Opinion (272)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (83)
Parkinson's disease (157)
Partnered (22)
Patents (239)
Patient recruitment (103)
Peanut (51)
People (63737)
Pharmaceutical (132)
Pharmacy benefit managers (21)
Phase I (22160)
Phase II (31269)
Phase III (23592)
Pipeline (1165)
Policy (161)
Postmarket research (3236)
Preclinical (9715)
Press Release (72)
Prostate cancer (103)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (420)
Real estate (7108)
Recruiting (75)
Regulatory (25849)
Reports (57)
Research institute (2654)
Resumes & cover letters (579)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (77)
Series A (137)
Series B (87)
Service/supplier (26)
Sickle cell disease (58)
Southern California (2255)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4179)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (29)
The Weekly (78)
United States (23508)
Vaccines (790)
Venture capitalists (41)
Weight loss (299)
Women's health (36)
Worklife (19)
Date
Today (11)
Last 7 days (512)
Last 30 days (2501)
Last 365 days (35429)
2025 (9946)
2024 (37895)
2023 (42567)
2022 (53926)
2021 (58722)
2020 (57663)
2019 (51302)
2018 (39083)
2017 (36796)
2016 (37687)
2015 (43689)
2014 (38254)
2013 (34208)
2012 (36150)
2011 (36224)
2010 (35523)
Location
Africa (1186)
Alabama (59)
Alaska (7)
Arizona (246)
Arkansas (14)
Asia (48135)
Australia (8278)
California (6067)
Canada (1983)
China (525)
Colorado (271)
Connecticut (288)
Delaware (144)
Europe (109310)
Florida (889)
Georgia (216)
Hawaii (1)
Idaho (63)
Illinois (590)
India (29)
Indiana (324)
Iowa (10)
Japan (154)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (929)
Massachusetts (4688)
Michigan (239)
Minnesota (406)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (26)
Nevada (62)
New Hampshire (68)
New Jersey (1748)
New Mexico (31)
New York (1725)
North Carolina (1088)
North Dakota (8)
Northern California (2600)
Ohio (209)
Oklahoma (15)
Oregon (45)
Pennsylvania (1347)
Puerto Rico (12)
Rhode Island (33)
South America (1562)
South Carolina (21)
South Dakota (1)
Southern California (2255)
Tennessee (102)
Texas (909)
Utah (182)
Virginia (158)
Washington D.C. (67)
Washington State (578)
West Virginia (3)
Wisconsin (63)
813,075 Results for "co diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results
March 28, 2025
·
10 min read
Press Releases
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast
March 13, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025
March 4, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Press Releases
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
January 31, 2025
·
2 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Press Releases
Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
February 21, 2025
·
4 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
1 of 81,308
Next
